Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,802 USD | -3,16% |
|
-7,95% | -7,68% |
Attività
Numero di dipendenti: 325
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drugs
100,0
%
| 157 | 100,0 % | 146 | 100,0 % | -7,03% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 157 | 100,0 % | 146 | 100,0 % | -7,03% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 26/02/20 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 25/02/19 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/23 |
Accumanno James
CMP | Compliance Officer | - | 01/05/21 |
Reshma Rangwala
CTO | Chief Tech/Sci/R&D Officer | 46 | 01/04/22 |
Elhan Webb
IRC | Investor Relations Contact | - | 14/03/22 |
Lisa DiPaolo
HRO | Human Resources Officer | - | 01/09/22 |
Stuart Poulton
PRN | Corporate Officer/Principal | 51 | 01/02/22 |
Sohanya Cheng
PRN | Corporate Officer/Principal | 41 | 08/06/21 |
Michael Mano
LAW | General Counsel | 47 | 15/12/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 03/10/13 |
Barry Greene
BRD | Director/Board Member | 60 | 01/01/13 |
Director/Board Member | 59 | 01/04/13 | |
Chen Schor
BRD | Director/Board Member | 51 | 25/11/20 |
Mansoor Mirza
BRD | Director/Board Member | 63 | 01/10/10 |
Richard Paulson
CEO | Chief Executive Officer | 56 | 26/02/20 |
Christy Oliger
BRD | Director/Board Member | 54 | 28/08/20 |
Su Zhen
BRD | Director/Board Member | 47 | 31/08/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 117 710 263 | 105 701 387 ( 89,80 %) | 0 | 89,80 % |
Coordinate società
Karyopharm Therapeutics, Inc.
85 Wells Avenue Suite 210, 2nd floor
02459-3298, Newton
+617 658 0600
http://www.karyopharm.com![Indirizzo Karyopharm Therapeutics Inc.(KPTI)](https://cdn.zonebourse.com/static/address/14825950.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-7,68% | 103 Mln | |
+16,60% | 121 Mrd | |
+17,85% | 110 Mrd | |
+16,97% | 25,98 Mrd | |
-24,17% | 19,27 Mrd | |
-18,56% | 15,99 Mrd | |
-18,02% | 15,66 Mrd | |
-47,75% | 14,5 Mrd | |
+57,22% | 14,47 Mrd | |
+5,16% | 13,91 Mrd |
- Borsa valori
- Azioni
- Azione KPTI
- Società Karyopharm Therapeutics Inc.